Pennsylvania Restricts Vaping Products as States Strengthen Youth Protections

New law reflects growing state efforts to prevent youth nicotine addiction amid continued concerns about FDA authorization of flavored e-cigarettes.

Pennsylvania is taking an important step to protect young people from nicotine addiction. Beginning October 19, 2026, the state will prohibit retailers from selling electronic cigarettes and vaping products not listed in its approved Electronic Nicotine Delivery System (ENDS) Directory.

The American Association for Respiratory Care (AARC) commends Pennsylvania for strengthening oversight of vaping products, particularly flavored disposable devices that appeal to adolescents. While the law is expected to remove many unauthorized products from store shelves, certain FDA-authorized products will remain available.

Pennsylvania joins a growing number of states regulating electronic cigarettes. A September 2026 study published in JAMA Network Open found that 16 states had enacted e-cigarette product-directory laws as of June 2026, with implementation dates spanning 2022 through 2027. Alabama, Oklahoma, and Louisiana were among the early adopters, while Virginia, Utah, and Wisconsin have also pursued similar approaches.

These laws reflect growing state efforts to restrict unauthorized vaping products and strengthen tobacco regulation enforcement.

According to the 2025 National Youth Tobacco Survey, approximately 1.44 million middle and high school students currently use e-cigarettes. Among youth who vape, 89.4% use flavored products, 66.3% use disposable devices, and 27.5% report daily use.

These findings underscore the importance of preventing youth access to nicotine products, particularly fruit, candy, and menthol flavors that can appeal to adolescents.

AARC Continues to Raise Concerns About FDA Decisions

While recognizing Pennsylvania’s efforts, AARC remains concerned about federal decisions authorizing flavored e-cigarettes.

In July 2025, AARC strongly opposed the FDA’s authorization of five JUUL products, particularly menthol-flavored pods, citing the company’s role in the youth vaping epidemic and the risks of adolescent nicotine addiction.

More recently, FDA authorization of certain Glas Inc.-manufactured flavored products, including fruit-flavored varieties, raised additional concerns among tobacco control advocates. Although the FDA cited age-verification technology and other safeguards, questions remain about whether these measures adequately prevent youth initiation.

Respiratory Therapists Have an Important Role

Respiratory therapists see firsthand the consequences of tobacco use and nicotine addiction. Through patient education, screening, cessation counseling, and advocacy, RTs play an essential role in preventing tobacco-related respiratory disease.

“Respiratory therapists are uniquely positioned to help patients break the cycle of tobacco and vaping addiction. We have the clinical expertise and patient relationships to make cessation counseling a routine part of respiratory care. AARC is actively advancing federal legislation that would expand opportunities for respiratory therapists to provide these important services and improve patient access to evidence-based cessation support. Strengthening the role of RTs in prevention and treatment is an important step toward reducing nicotine addiction and improving respiratory health.” Says Jefferson Mixell, MBA, RRT, RRT ACCS, Legislative Committee Chair, Pennsylvania Society for Respiratory Care.

Pennsylvania deserves recognition for taking action to limit youth access to unauthorized vaping products. However, product-directory laws are only one component of a comprehensive tobacco prevention strategy. As more states pursue similar legislation, AARC will continue to advocate for strong youth protections, effective enforcement, evidence-based cessation resources, and greater accountability in federal decisions involving flavored nicotine products.